DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding DiaMedica Therapeutics Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 78 | 92 | +14 |
| Shares | 12.8M | 12.1M | −700.6K (−5.5%) |
| Value | $82.8M | $96.0M | +$13.2M (+15.9%) |
New holders (22)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (8)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| CI Private Wealth, LLC | 140,000 | $961.8K |
| Corient IA LLC | 132,500 | $910.3K |
| Cantor Fitzgerald, L. P. | 100,000 | $687.0K |
| Jane Street Group, LLC | 57,546 | $395.3K |
| Qube Research & Technologies Ltd | 39,549 | $271.7K |
| Man Group plc | 19,414 | $133.4K |
| Tortoise Investment Management, LLC | 500 | $3.44K |
| SRS Capital Advisors, Inc. | 32 | $219 |